FCVTX
Price
$22.96
Change
-$0.20 (-0.86%)
Updated
Aug 20 closing price
Net Assets
5.47B
UBVVX
Price
$90.50
Change
+$0.56 (+0.62%)
Updated
Aug 21 closing price
Net Assets
9.03B
Interact to see
Advertisement

FCVTX vs UBVVX

FCVTX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
FCVTX vs. UBVVX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCVTX is a Hold and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.03B vs. FCVTX (5.47B). UBVVX pays higher dividends than FCVTX: UBVVX (1.59) vs FCVTX (0.56). FCVTX was incepted earlier than UBVVX: FCVTX (22 years) vs UBVVX (9 years). FCVTX (1.45) is less costly to investors than UBVVX (0.94). FCVTX is a more actively managed with annual turnover of: 96.00 vs. UBVVX (35.00). FCVTX (0) and UBVVX (0) have matching initial minimum investment requirements. FCVTX annual gain was more profitable for investors over the last year : 21.06 vs. UBVVX (8.29). UBVVX return over 5 years is better than : 20.79 vs. FCVTX (16.24).
FCVTXUBVVXFCVTX / UBVVX
Total Expense Ratio1.450.90161%
Annual Report Gross Expense Ratio1.450.94154%
Fund Existence22 years9 years-
Gain YTD26.29315.773167%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.47B9.03B61%
Annual Yield % from dividends0.561.5935%
Returns for 1 year21.068.29254%
Returns for 3 years34.3224.31141%
Returns for 5 years16.2420.7978%
Returns for 10 years33.70N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRBP10.380.54
+5.49%
Corbus Pharmaceuticals Holdings
ANF109.013.99
+3.80%
Abercrombie & Fitch Co
RGNT2.100.04
+1.94%
Regentis Biomaterials Ltd
AME239.550.47
+0.20%
Ametek
CPAC11.71-0.07
-0.59%
Cementos Pacasmayo SAA